DE60316024D1 - Natürliche vitamin-e-zusammsetzungen mitausgezeichneter antioxidationswirksamkeit - Google Patents

Natürliche vitamin-e-zusammsetzungen mitausgezeichneter antioxidationswirksamkeit

Info

Publication number
DE60316024D1
DE60316024D1 DE60316024T DE60316024T DE60316024D1 DE 60316024 D1 DE60316024 D1 DE 60316024D1 DE 60316024 T DE60316024 T DE 60316024T DE 60316024 T DE60316024 T DE 60316024T DE 60316024 D1 DE60316024 D1 DE 60316024D1
Authority
DE
Germany
Prior art keywords
compositions
alpha
tocopherol
natural vitamin
effectiveness
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60316024T
Other languages
English (en)
Inventor
Yousry Naguib
Ronald Udell
Richard Passwater Jr
Melvin Rich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Soft Gel Technologies Inc
Original Assignee
Soft Gel Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soft Gel Technologies Inc filed Critical Soft Gel Technologies Inc
Application granted granted Critical
Publication of DE60316024D1 publication Critical patent/DE60316024D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60316024T 2002-12-17 2003-12-17 Natürliche vitamin-e-zusammsetzungen mitausgezeichneter antioxidationswirksamkeit Expired - Lifetime DE60316024D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/321,318 US7329688B2 (en) 2002-12-17 2002-12-17 Natural vitamin E compositions with superior antioxidant potency
PCT/US2003/040398 WO2004056348A2 (en) 2002-12-17 2003-12-17 Natural vitamin e compositions with superior antioxidant potency

Publications (1)

Publication Number Publication Date
DE60316024D1 true DE60316024D1 (de) 2007-10-11

Family

ID=32507093

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60316024T Expired - Lifetime DE60316024D1 (de) 2002-12-17 2003-12-17 Natürliche vitamin-e-zusammsetzungen mitausgezeichneter antioxidationswirksamkeit

Country Status (6)

Country Link
US (4) US7329688B2 (de)
EP (1) EP1572195B1 (de)
AT (1) ATE371447T1 (de)
AU (1) AU2003301069B2 (de)
DE (1) DE60316024D1 (de)
WO (1) WO2004056348A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716451B1 (en) * 1999-11-30 2004-04-06 Soft Gel Technologies, Inc. Formulation and delivery method to enhance antioxidant potency of vitamin E
JP2005501094A (ja) * 2001-08-21 2005-01-13 ガリレオ ファーマシューティカルズ， インコーポレイティド トコフェロール富化組成物および炎症性症状の回復
AU2002352726A1 (en) * 2001-11-15 2003-06-10 Galileo Laboratories, Inc. Formulations and methods for treatment or amelioration of inflammatory conditions
MXPA04012740A (es) * 2002-07-02 2005-03-23 Galileo Pharmaceuticals Inc Composiciones y metodos para reduccion de sintomas inflamatorios y/o biomarcadores en pacientes femeninos.
US7329688B2 (en) * 2002-12-17 2008-02-12 Soft Gel Technologies, Inc. Natural vitamin E compositions with superior antioxidant potency
CA2545788A1 (en) * 2003-11-13 2005-06-02 Galileo Pharmaceuticals, Inc. Plant-derived protein extract compositions and methods
US20080038316A1 (en) * 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
US20070021497A1 (en) * 2005-07-11 2007-01-25 The Fruitful Yield Vitamin e compositions
CA2618655C (en) * 2005-07-18 2015-12-22 University Of Massachusetts Lowell Compositions and methods for making and using nanoemulsions
HUP0500975A2 (en) * 2005-10-25 2008-02-28 Arpad Tosaki Process for producing of extract of sour cherry seed, use of extract for producing of medicament and medicaments consist extract
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
US10251861B2 (en) 2012-06-08 2019-04-09 Ohio State Innovation Foundation Methods for treating burn and scar injury using tocotrienol compositions
AU2017315679B2 (en) 2016-08-23 2023-12-14 Akouos, Inc. Compositions and methods for treating non-age-associated hearing impairment in a human subject
BR112019010131A2 (pt) 2016-11-21 2019-10-08 Eirion Therapeutics Inc entrega transdérmica de agentes grandes
AU2021225035A1 (en) 2020-02-21 2022-10-13 Akouos, Inc. Compositions and methods for treating non-age-associated hearing impairment in a human subject

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2940900A (en) * 1957-09-25 1960-06-14 Eastman Kodak Co Dry vitamine e composition
US3102078A (en) * 1961-01-13 1963-08-27 Eastman Kodak Co Water-dispersible vitamin preparations
US3212901A (en) * 1961-06-07 1965-10-19 Eastman Kodak Co Stabilized tocopherol concentrates and process for preparing the same
US3564097A (en) * 1968-04-05 1971-02-16 Louis Magid Stable multivitamin tablets containing tricalcium phosphate
US4364945A (en) * 1979-12-13 1982-12-21 Whittle Barry J Nasal composition for relieving nasal distress
US4551332A (en) * 1981-08-05 1985-11-05 Theodore Stillman Vitamin E compositions and methods
US5948769A (en) 1984-01-28 1999-09-07 Ismail; Roshdy Agent for treating heart diseases
US4612194A (en) * 1984-02-15 1986-09-16 Roshdy Ismail Anti-rheumatic agents and their use
US4711894A (en) * 1986-01-16 1987-12-08 Henkel Corporation Stabilized tocopherol in dry, particulate, free-flowing form
DE3805927A1 (de) * 1988-02-25 1989-08-31 Bosch Gmbh Robert Vorrichtung zur verbesserung der gemischverteilung
US5217992A (en) * 1989-10-04 1993-06-08 Bristol-Myers Squibb Company Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders
FR2657526B1 (fr) * 1990-01-31 1994-10-28 Lvmh Rech Utilisation d'un phosphate d'alpha-tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, dermatologiques, ou pharmaceutiques; compositions ainsi obtenues.
US5114957A (en) * 1990-05-08 1992-05-19 Biodor U.S. Holding Tocopherol-based antiviral agents and method of using same
US5102659A (en) 1990-07-12 1992-04-07 Shaklee Corporation Natural antioxidant compositions
US5179122A (en) * 1991-02-11 1993-01-12 Eastman Kodak Company Nutritional supplement containing vitamin e
CA2124086A1 (en) * 1991-11-22 1993-05-27 Ronald H. Lane Tocotrienols and tocotrienol-like compounds and methods for their use
US5545398A (en) * 1993-01-13 1996-08-13 Perricone; Nicholos V. Method and compositions for topical application to the skin of tocotrienol for prevention and/or treatment of skin damage
US5376361A (en) * 1993-01-13 1994-12-27 Perricone; Nicholas V. Method and compositions for topical application to the skin for prevention and/or treatment of radiation-induced skin damage
US5352696A (en) * 1993-01-22 1994-10-04 Pacific Corporation Quaternary nitrogen-containing vitamin E derivatives and uses thereof
JP3651915B2 (ja) 1993-06-30 2005-05-25 財団法人神奈川科学技術アカデミー シグナル配列ペプチドをコードするｄｎａ断片の探索法及びそのためのベクター
WO1996019218A1 (en) * 1994-12-22 1996-06-27 Henkel Corporation Tocopherol and tocotrienol compositions
US6358997B1 (en) * 1995-12-22 2002-03-19 Cognis Corporation Tocopherol and tocotrienol compositions
MXPA00002122A (es) * 1997-08-29 2003-06-09 Ricex Company Inc Un metodo para tratar la diabetes, la hiperglucemia y la hipoglucemia.
US5985344A (en) * 1997-09-02 1999-11-16 The Ricex Company Process for obtaining micronutrient enriched rice bran oil
US5997892A (en) * 1997-10-09 1999-12-07 Camp; Gary Don Topical therapeutic composition for and method of treating psoriasis
US6277431B1 (en) * 1998-10-14 2001-08-21 Redeem, Inc. Anticholesterolemic edible oil
US6048891A (en) * 1998-12-17 2000-04-11 Loma Linda University Medical Center Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of natriuretic disease
US6716451B1 (en) * 1999-11-30 2004-04-06 Soft Gel Technologies, Inc. Formulation and delivery method to enhance antioxidant potency of vitamin E
US7329688B2 (en) 2002-12-17 2008-02-12 Soft Gel Technologies, Inc. Natural vitamin E compositions with superior antioxidant potency

Also Published As

Publication number Publication date
AU2003301069A1 (en) 2004-07-14
EP1572195B1 (de) 2007-08-29
US20110251274A1 (en) 2011-10-13
US20060093664A1 (en) 2006-05-04
US20090156664A1 (en) 2009-06-18
US7449491B2 (en) 2008-11-11
EP1572195A2 (de) 2005-09-14
WO2004056348A3 (en) 2004-09-10
US7989493B2 (en) 2011-08-02
ATE371447T1 (de) 2007-09-15
US7329688B2 (en) 2008-02-12
WO2004056348A2 (en) 2004-07-08
AU2003301069B2 (en) 2010-11-18
US20040116512A1 (en) 2004-06-17

Similar Documents

Publication Publication Date Title
DE60316024D1 (de) Natürliche vitamin-e-zusammsetzungen mitausgezeichneter antioxidationswirksamkeit
DK0977562T3 (da) Fremgangsmåder og sammensætninger til indgivelse af taxaner
TW200626132A (en) Topical nepafenac formulations
DK1802274T3 (da) Anvendelse af cannabidiol i inhibitionen af hjernetumorcellemigration
NO20040917L (no) Oftamologiske depotpreparater for periokular eller subkonjunktival administrering.
WO2005048929A3 (en) Plant-derived protein extract compositions and methods
BR0210139A (pt) Composições farmacêuticas
AU2002353971A1 (en) Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
AU2002327180A1 (en) Detection and therapy of vulnerable plaque with photodynamic compounds
RS51569B (en) COMPOSITIONS CONTAINING CRYSTAL TRANS - (+/-) - DELTA-9-TETRAHYDROCANABINOL
SG156613A1 (en) Use of mitochondrially targeted antioxidant in the treatment of liver diseases and epithelial cancers
BRPI0408589A (pt) suplementos dietéticos à base de fruta de açai e juçara
MXPA04006039A (es) Metodo para el tratamiento de afecciones vasculares y neuronales perifericas.
AR061707A2 (es) Metodo para el tratamiento de insuficiencias venosas cronicas utilizando un extracto de hojas de vid roja
NO20061236L (no) Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og paratyroidhoziiton
ATE416629T1 (de) Antioxidative zusammensetzungen
AU3287200A (en) Composition comprising isoquercetin and ascorbic acid in a sustained release form
DK1196174T3 (da) Diætmæssigt calcium, som et tilskud til D-vitamin-forbindelsesbehandling af multipel sclerose
ATE361743T1 (de) Beschichtete minitabletten von venlafaxinhydrochlorid mit verlängerter freisetzung
DK1383516T3 (da) Indgivelse af et polysaccharid samtidig med et kemoterapeutisk middel til behandling af cancer
WO2005000204A3 (en) Pancreatic cancer treatment
WO2002078690A3 (en) Taxoid anti-tumor agents and pharmaceutical compositions thereof
MXPA03006477A (es) Metodo de tratamiento de diabetes tipo i.
WO2004010974A3 (en) Gelatin capsule exhibiting reduced cross-linking
AU2003281468A1 (en) P-glycoprotein inhibitor comprising octilonium bromide as an effective ingredient

Legal Events

Date Code Title Description
8332 No legal effect for de